ASCPT SIGN IN
Username:
Password:
SEARCH
2017 ASCPT Board of Directors Appointments

ASCPT is pleased to announce that beginning in March 2017, Daniel L. Hartman, MD, FCCP, will serve a 1-year term as president-elect of the American Society for Clinical Pharmacology and Therapeutics (ASCPT).
Also joining the Board of Directors as of March 2017 are:

David Y. Mitchell, PhD, will continue his 3-year term as an at-large director for the American Society for Clinical Pharmacology and Therapeutics (ASCPT).  Dr.  Mitchell completed an unexpired term for an immediate past president in 2015 and served a 1-year appointment in 2016. 

Jill Fiedler-Kelly, MS is one of the newest members of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Board of Directors.  Ms. Fiedler-Kelly will serve a 3-year term as an at-large director.

Paolo Vicini, PhD, MBA, is one of the newest members of the American Society for Clinical Pharmacology and Therapeutics (ASCPT) Board of Directors. Dr. Vicini will serve a 3-year term as an at-large director. 

 Please join us in congratulating these newly appointed members of the Board of Directors. 
528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |  info@ascpt.org